UBS Group’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.63M | Sell |
|
|||||
|
2025
Q2 | $2.44M | Sell |
|
|||||
|
2025
Q1 | $4.56M | Buy |
|
|||||
|
2024
Q4 | $2.37M | Sell |
|
|||||
|
2024
Q3 | $5.94M | Buy |
|
|||||
|
2024
Q2 | $5.05M | Buy |
|
|||||
|
2024
Q1 | $519K | Sell |
|
|||||
|
2023
Q4 | $1.01M | Buy |
|
|||||
|
2023
Q3 | $444K | Sell |
|
|||||
|
2023
Q2 | $989K | Buy |
|
|||||
|
2023
Q1 | $722K | Sell |
|
|||||
|
2022
Q4 | $1.54M | Buy |
|
|||||
|
2022
Q3 | $429K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $387K | Sell |
|
|||||
|
2021
Q4 | $622K | Buy |
|
|||||
|
2021
Q3 | $18K | Buy |
|
|||||
|
2021
Q2 | $9K | Sell |
|
|||||
|
2021
Q1 | $156K | Sell |
|
|||||
|
2020
Q4 | $200K | Buy |
|
|||||
|
2020
Q3 | $72K | Sell |
|
|||||
|
2020
Q2 | $100K | Sell |
|
|||||
|
2020
Q1 | $162K | Sell |
|
|||||
|
2019
Q4 | $557K | Buy |
|
|||||
|
2019
Q3 | $325K | Buy |
|
|||||
|
2019
Q2 | $144K | Buy |
|
|||||
|
2019
Q1 | $52K | Sell |
|
|||||
|
2018
Q4 | $152K | Buy |
|
|||||
|
2018
Q3 | $147K | Buy |
|
|||||
|
2018
Q2 | $135K | Buy |
|
|||||
|
2018
Q1 | $111K | Buy |
|
|||||
|
2017
Q4 | $118K | Buy |
|
|||||
|
2017
Q3 | $130K | Buy |
|
|||||
|
2017
Q2 | $106K | Buy |
|
|||||
|
2017
Q1 | $75K | Sell |
|
|||||
|
2016
Q4 | $206K | Buy |
|
|||||
|
2016
Q3 | $102K | Sell |
|
|||||
|
2016
Q2 | $250K | Sell |
|
|||||
|
2016
Q1 | $513K | Buy |
|
|||||
|
2015
Q4 | $600K | Buy |
|
|||||
|
2015
Q3 | $116K | Buy |
|
|||||
|
2015
Q2 | $54K | Buy |
|
|||||
|
2015
Q1 | $6K | Sell |
|
|||||
|
2014
Q4 | $42K | Buy |
|